Six-year follow-up from the weekly-three-weekly study comparing cisplatin once-a-week to once-every-three-weeks as concurrent chemoradiation for locally advanced head and neck squamous cell carcinoma.

Vanita Noronha, Kumar Prabhash, Nandini Sharrel Menon et al.|Journal of Clinical Oncology|2022

Cited by 3